QOLOREX
DEAD

Serial Number

98245629

Owner

Beeta Biomed Inc.

Attorney

Nathan T. Harris

Filing Date

Oct 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

QOLOREX Trademark

Serial Number: 98245629

QOLOREX is a trademark filed by Beeta Biomed Inc. on October 30, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Beeta Biomed Inc. (2 trademarks)

2224 Chemin Seneca
Mont Royal, QC QCH3P2N3 , CA

Entity Type: 03

Trademark Details

Filing Date

October 30, 2023

Registration Date

Not Registered

Goods & Services

laboratory devices for detecting biomarkers for disease diagnosis not for medical purposes; downloadable software for controlling laboratory devices and analyzing data related to biomarker detection in research laboratories; Nonmedical laboratory equipment and supplies, namely, apparatus and instruments for detecting biomarkers, automated devices for detecting biomarkers, diagnostic apparatus for research laboratory use, measuring apparatus for measuring optical intensity, florescence intensity, electrochemical changes, optical apparatus and instruments in the nature of fluorometers, spectrometers, and microscopes; laboratory equipment and supplies for collecting, storing, preparing, handling, and analyzing specimens used to detect biomarkers, namely, cartridges sold empty, test tubes, reagent tubes sold empty, test strips, test plates sold empty, test cups, funnels for collecting, storing, preparing, handling, and/or analyzing specimens used to detect biomarkers; Non-medical diagnostic equipment and supplies for collecting, storing, preparing, handling, and analyzing specimens used to detect biomarkers, namely, cartridges sold empty, test tubes, reagent tubes sold empty, test strips, test plates sold empty, test cups, funnels for collecting, storing, preparing, handling, and/or analyzing specimens used to detect biomarkers

Fluidic cartridges and fluidic containers sold filled with reagents, namely, antibodies, nucleic acid primers, enzymes, small molecules, proteins, colorimetric dyes, or florescent probes for medical, veterinary, and therapeutic purposes; diagnostic preparations for medical purposes used by medical laboratories, namely, fluidic cartridges and containers sold filled with nucleic acid primers, enzymes, small molecules, proteins, colorimetric dyes, or florescent probes; Reagent tubes, namely, tubes sold filled with diagnostic biomarker reagents for medical purposes; reagent bearing medical test strips for detecting biomarkers

maintenance, repair, and configuration of laboratory devices

diagnostic preparations for research laboratory use, namely, fluidic cartridges and containers sold filled with biomarker detection reagents, namely, nucleic acid primers, enzymes, small molecules, proteins, colorimetric dyes, or florescent probes; Reagent tubes, namely, tubes sold filled with diagnostic biomarker reagents for non-medical research purposes; reagent bearing non-medical test strips for detecting biomarkers

training and consulting in the field of medicine, namely, for detecting biomarkers for medical purposes

diagnostic apparatus for medical purposes used in medical laboratories for testing biomarkers for infectious diseases, antimicrobial resistance detection, cancer, cardiovascular diseases, inflammatory conditions, and chronic kidney disorders; laboratory devices for detecting biomarkers for disease diagnosis, prognosis, and development of treatment plans for medical purposes; Medical diagnostic equipment and supplies for collecting, storing, preparing, handling, and analyzing specimens used to detect biomarkers, namely, cartridges sold empty, test tubes, reagent tubes sold empty, test plates sold empty, test cups, funnels

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 6, 2025 ABN2
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Feb 20, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Feb 20, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Feb 20, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 13, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 13, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 13, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 11, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 11, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 11, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 11, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2023 NWOS
NEW APPLICATION ENTERED
Nov 2, 2023 NWAP